© 1995 by Oxford University Press
Journal of the National Cancer Institute, Vol. 87, No. 16, 1224-1229,
August 16, 1995
© 1995 Oxford University Press
Allele-Specific Loss in Chromosome 9p Loci in Preneoplastic Lesions Accompanying Non-Small-Cell Lung Cancers
1Simmons Cancer Center, The University of Texas Southwestern MedicaJ Center Dallas
2Simmons Cancer Center and Department of Pathology, The University of Texas Southwestern MedicaJ Center Dallas
3Simmons Cancer Center and Academic Computing Services, The University of Texas Southwestern MedicaJ Center Dallas
4Simmons Cancer Center and Department of Internal Medicine, The University of Texas Southwestern MedicaJ Center Dallas
Correspondence to: Adi F. Gazdar, M.D., Simmons Cancer Center, UT Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75235–8593.
Background: Carcinogenesis is a multistep process, which may begin as a consequence of chromosomal changes. Deletions in the short arm of chromosome 9 (9p) have been observed in lung carcinomas. In addition, morphologically recognizable preneoplastic lesions, frequently multiple in number, precede onset of invasive carcinomas. Purpose: We tested for deletions and loss of heterozygosity (LOH) at 9p loci in preneoplastic and neoplastic foci in lungs of patients with non-small-cell lung carcinomas (NSCLCs). Methods: Seven archival, paraffin-embedded, surgically resected NSCLC specimens were selected. They were predominantly from patients with adenocarcinomas and contained multiple preneoplastic lesions, including hyperplasia, metaplasia, dysplasia, and carcinoma in situ (CIS). Fifty-three histologi-cally identified preneoplastic and malignant lesions present in bronchi, bronchioles, and alveoli were precisely microdis-sected from stained tissue sections with a micromanipulator. Stromal lymphocytes were used to determine constitutional heterozygosity. The specimens were analyzed for LOH using polymerase chain reaction-based assays for polymorphism in dinucleotide repeats (microsatellite markers) in interferon alfa (IFNA) and D9S171 loci on 9p. Results: All seven cases were constitutionally heterozygous for one or both microsatellite markers. Five of seven cases had LOH at one or both 9p loci in the invasive primary cancers (doubly informative cases). Four of these five cases also revealed LOH in preneoplastic foci. In the doubly informative cases, LOH was detected in five (38%) of 13 foci of hyperplasia, four (80%) of five foci of dysplasia, and three (100%) of three CIS lesions. LOH was detected in preneoplastic lesions from all regions of the respiratory tract, including bronchi, bronchioles, and alveoli, and involved five different cell types. The identical allele was lost from both the preneoplastic lesions and the corresponding tumors (12 of 12 lesions, 17 of 17 comparisons), a phenomenon we have referred to as "allele-specific mutation." Statistical analyses employing a cumulative binomial test demonstrated that the probabilities of such findings occurring by chance are 2.4 x 10–4 and 7.6 x 10–6, respectively. From comparisons with the previously published data on other chromosomal abnormalities in the same tissue specimens, it appears that LOH at 3p and 9p loci occurred early in the hyperplasia stage, but the ras gene point mutations were relatively late, at the CIS stage. Conclusions: LOH at 9p loci occurs at the earliest stage in the pathogenesis of lung cancer and involves all regions of the respiratory tract. LOH in NSCLC is not random but targets a specific allele in individuals. Studying preneoplastic lesions may help identify intermediate markers for risk assessment and chemoprevention. [J Natl Cancer Inst 87: 1224–1229, 1995]
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  X. Wang, M. Wang, G. T. MacLennan, F. W. Abdul-Karim, J. N. Eble, T. D. Jones, F. Olobatuyi, R. Eisenberg, O. W. Cummings, S. Zhang, et al. Evidence for Common Clonal Origin of Multifocal Lung Cancers J Natl Cancer Inst, April 15, 2009; 101(8): 560 - 570. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. E. Miller, P. Blatchford, D. S. Hyun, R. L. Keith, T. C. Kennedy, H. Wolf, T. Byers, P. A. Bunn Jr., M. T. Lewis, W. A. Franklin, et al. Bronchial Epithelial Ki-67 Index Is Related to Histology, Smoking, and Gender, but Not Lung Cancer or Chronic Obstructive Pulmonary Disease Cancer Epidemiol. Biomarkers Prev., November 1, 2007; 16(11): 2425 - 2431. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. E. Miller Pathogenesis of Lung Cancer: 100 Year Report Am. J. Respir. Cell Mol. Biol., September 1, 2005; 33(3): 216 - 223. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Meuwissen and A. Berns Mouse models for human lung cancer Genes & Dev., March 15, 2005; 19(6): 643 - 664. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Moro-Sibilot, F. Fievet, M. Jeanmart, S. Lantuejoul, F. Arbib, M.H. Laverriere, E. Brambilla, and C. Brambilla Clinical prognostic indicators of high-grade pre-invasive bronchial lesions Eur. Respir. J., July 1, 2004; 24(1): 24 - 29. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Lubet, Z. Zhang, Y. Wang, and M. You Chemoprevention of Lung Cancer in Transgenic Mice Chest, May 1, 2004; 125(5_suppl): 144S - 147S. [Full Text] [PDF]
|
|
|
|
 |
|
 K M Fong, Y Sekido, A F Gazdar, and J D Minna Lung cancer * 9: Molecular biology of lung cancer: clinical implications Thorax, October 1, 2003; 58(10): 892 - 900. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Ratschiller, J. Heighway, M. Gugger, A. Kappeler, F. Pirnia, R.A. Schmid, M.M. Borner, and D.C. Betticher Cyclin D1 Overexpression in Bronchial Epithelia of Patients With Lung Cancer Is Associated With Smoking and Predicts Survival J. Clin. Oncol., June 1, 2003; 21(11): 2085 - 2093. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Jeanmart, S. Lantuejoul, F. Fievet, D. Moro, N. Sturm, C. Brambilla, and E. Brambilla Value of Immunohistochemical Markers in Preinvasive Bronchial Lesions in Risk Assessment of Lung Cancer Clin. Cancer Res., June 1, 2003; 9(6): 2195 - 2203. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A K Banerjee, P H Rabbitts, and J George Lung cancer * 3: Fluorescence bronchoscopy: clinical dilemmas and research opportunities Thorax, March 1, 2003; 58(3): 266 - 271. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Piyathilake, A. R. Frost, U. Manne, H. Weiss, D. C. Heimburger, and W. E. Grizzle Nuclear Accumulation of p53 Is a Potential Marker for the Development of Squamous Cell Lung Cancer in Smokers Chest, January 1, 2003; 123(1): 181 - 186. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Brambilla, F. Fievet, M. Jeanmart, F. de Fraipont, S. Lantuejoul, V. Frappat, G. Ferretti, P.Y. Brichon, and D. Moro-Sibilot Early detection of lung cancer: role of biomarkers Eur. Respir. J., January 1, 2003; 21(39_suppl): 36S - 44s. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.K. Field and J.H. Youngson The Liverpool Lung Project: a molecular epidemiological study of early lung cancer detection Eur. Respir. J., August 1, 2002; 20(2): 464 - 479. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F.R. Hirsch, D.T. Merrick, and W.A. Franklin Role of biomarkers for early detection of lung cancer and chemoprevention Eur. Respir. J., June 1, 2002; 19(6): 1151 - 1158. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Uematsu, A. Yoshimura, A. Gemma, H. Mochimaru, Y. Hosoya, S. Kunugi, K. Matsuda, M. Seike, F. Kurimoto, K. Takenaka, et al. Aberrations in the Fragile Histidine Triad (FHIT) Gene in Idiopathic Pulmonary Fibrosis Cancer Res., December 1, 2001; 61(23): 8527 - 8533. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Takamochi, T. Ogura, K. Suzuki, H. Kawasaki, Y. Kurashima, T. Yokose, A. Ochiai, K. Nagai, Y. Nishiwaki, and H. Esumi Loss of Heterozygosity on Chromosomes 9q and 16p in Atypical Adenomatous Hyperplasia Concomitant with Adenocarcinoma of the Lung Am. J. Pathol., November 1, 2001; 159(5): 1941 - 1948. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Fisher, A. K. Virmani, L. Wu, R. Aplenc, J. C. Harper, S. M. Powell, T. R. Rebbeck, D. Sidransky, A. F. Gazdar, and W. S. El-Deiry Nucleotide Substitution in the Ectodomain of TRAIL Receptor DR4 Is Associated with Lung Cancer and Head and Neck Cancer Clin. Cancer Res., June 1, 2001; 7(6): 1688 - 1697. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Roth, N. Hu, M. R. Emmert-Buck, Q.-H. Wang, S. M. Dawsey, G. Li, W.-J. Guo, Y.-Z. Zhang, and P. R. Taylor Genetic Progression and Heterogeneity Associated with the Development of Esophageal Squamous Cell Carcinoma Cancer Res., May 1, 2001; 61(10): 4098 - 4104. [Abstract] [Full Text]
|
|
|
|
|
|
F. R. Khuri, J. S. Lee, S. M. Lippman, J. J. Lee, S. Kalapurakal, R. Yu, J. Y. Ro, R. C. Morice, W. K. Hong, and W. N. Hittelman Modulation of Proliferating Cell Nuclear Antigen in the Bronchial Epithelium of Smokers Cancer Epidemiol. Biomarkers Prev., April 1, 2001; 10(4): 311 - 318. [Abstract] [Full Text]
|
|
|
|
|
|
T. Liloglou, P. Maloney, G. Xinarianos, M. Hulbert, M. J. Walshaw, J. R. Gosney, L. Turnbull, and J. K. Field Cancer-specific Genomic Instability in Bronchial Lavage: A Molecular Tool for Lung Cancer Detection Cancer Res., February 1, 2001; 61(4): 1624 - 1628. [Abstract] [Full Text]
|
|
|
|
|
|
J. O. Boyle, F. Lonardo, J. H. Chang, D. Klimstra, V. Rusch, and E. Dmitrovsky Multiple High-Grade Bronchial Dysplasia and Squamous Cell Carcinoma: Concordant and Discordant Mutations Clin. Cancer Res., February 1, 2001; 7(2): 259 - 266. [Abstract] [Full Text]
|
|
|
|
|
|
T. Hirao, H. H. Nelson, T. D. S. Ashok, J. C. Wain, E. J. Mark, D. C. Christiani, J. K. Wiencke, and K. T. Kelsey Tobacco Smoke-induced DNA Damage and an Early Age of Smoking Initiation Induce Chromosome Loss at 3p21 in Lung Cancer Cancer Res., January 1, 2001; 61(2): 612 - 615. [Abstract] [Full Text]
|
|
|
|
|
|
F. R. Hirsch, W. A. Franklin, A. F. Gazdar, and P. A. Bunn Jr. Early Detection of Lung Cancer: Clinical Perspectives of Recent Advances in Biology and Radiology Clin. Cancer Res., January 1, 2001; 7(1): 5 - 22. [Abstract] [Full Text]
|
|
|
|
|
|
S. Shimizu, Y. Yatabe, T. Koshikawa, N. Haruki, S. Hatooka, M. Shinoda, M. Suyama, M. Ogawa, N. Hamajima, R. Ueda, et al. High Frequency of Clonally Related Tumors in Cases of Multiple Synchronous Lung Cancers as Revealed by Molecular Diagnosis Clin. Cancer Res., October 1, 2000; 6(10): 3994 - 3999. [Abstract] [Full Text]
|
|
|
|
|
|
Y. Yatabe, H. Konishi, T. Mitsudomi, S. Nakamura, and T. Takahashi Topographical Distributions of Allelic Loss in Individual Non-Small-Cell Lung Cancers Am. J. Pathol., September 1, 2000; 157(3): 985 - 993. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. I. Wistuba, J. Berry, C. Behrens, A. Maitra, N. Shivapurkar, S. Milchgrub, B. Mackay, J. D. Minna, and A. F. Gazdar Molecular Changes in the Bronchial Epithelium of Patients with Small Cell Lung Cancer Clin. Cancer Res., July 1, 2000; 6(7): 2604 - 2610. [Abstract] [Full Text]
|
|
|
|
|
|
N. Martinet, F. Alla, G. Farre, T. Labib, H. Drouot, R. Vidili, E. Picard, M.-P. Gaube, D. Le Faou, J. Siat, et al. Retinoic Acid Receptor and Retinoid X Receptor Alterations in Lung Cancer Precursor Lesions Cancer Res., June 1, 2000; 60(11): 2869 - 2875. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. N. ROM, J. G. HAY, T. C. LEE, Y. JIANG, and K.-M. TCHOU-WONG Molecular and Genetic Aspects of Lung Cancer Am. J. Respir. Crit. Care Med., April 1, 2000; 161(4): 1355 - 1367. [Full Text]
|
|
|
|
|
|
W. A. Franklin Diagnosis of Lung Cancer : Pathology of Invasive and Preinvasive Neoplasia Chest, April 1, 2000; 117 (2009): 80S - 89S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Moldvay, P. Scheid, P. Wild, K. Nabil, J. Siat, J. Borrelly, B. Marie, G. Farré, T. Labib, G. Pottier, et al. Predictive Survival Markers in Patients with Surgically Resected Non-Small Cell Lung Carcinoma Clin. Cancer Res., March 1, 2000; 6(3): 1125 - 1134. [Abstract] [Full Text]
|
|
|
|
|
|
G. J. Kelloff, C. C. Sigman, K. M. Johnson, C. W. Boone, P. Greenwald, J. A. Crowell, E. T. Hawk, and L. A. Doody Perspectives on Surrogate End Points in the Development of Drugs that Reduce the Risk of Cancer Cancer Epidemiol. Biomarkers Prev., February 1, 2000; 9(2): 127 - 137. [Abstract] [Full Text]
|
|
|
|
|
|
P. C. Galipeau, L. J. Prevo, C. A. Sanchez, G. M. Longton, and B. J. Reid Clonal Expansion and Loss of Heterozygosity at Chromosomes 9p and 17p in Premalignant Esophageal (Barrett's) Tissue J Natl Cancer Inst, December 15, 1999; 91(24): 2087 - 2095. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. Fong, Y. Sekido, and J. D. Minna MOLECULAR PATHOGENESIS OF LUNG CANCER J. Thorac. Cardiovasc. Surg., December 1, 1999; 118(6): 1136 - 1152. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. N. Hittelman Clones and Subclones in the Lung Cancer Field J Natl Cancer Inst, November 3, 1999; 91(21): 1796 - 1799. [Full Text] [PDF]
|
|
|
|
|
|
I.-W. Park, I. I. Wistuba, A. Maitra, S. Milchgrub, A. K. Virmani, J. D. Minna, and A. F. Gazdar Multiple Clonal Abnormalities in the Bronchial Epithelium of Patients With Lung Cancer J Natl Cancer Inst, November 3, 1999; 91(21): 1863 - 1868. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Pilon, M. Pistorello, A. Moscon, G. Altavilla, U. Pagotto, M. Boscaro, and F. Fallo Inactivation of the p16 Tumor Suppressor Gene in Adrenocortical Tumors J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2776 - 2779. [Abstract] [Full Text]
|
|
|
|
|
|
C. A. Powell, S. Klares, G. O'Connor, and J. S. Brody Loss of Heterozygosity in Epithelial Cells Obtained by Bronchial Brushing: Clinical Utility in Lung Cancer Clin. Cancer Res., August 1, 1999; 5(8): 2025 - 2034. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. C. Flowers, I. I. Wistuba, J. Scurry, C. Y. Muller, R. Ashfaq, D. S. Miller, J. D. Minna, and A. F. Gazdar Genetic Changes During the Multistage Pathogenesis of Human Papiloomavirus Positive and Negative Vulvar Carcinomas Reproductive Sciences, July 1, 1999; 6(4): 213 - 221. [Abstract] [PDF]
|
|
|
|
|
|
Y. Tomizawa, J.-i. Adachi, T. Kohno, K. Hamada, R. Saito, M. Noguchi, Y. Matsuno, S. Hirohashi, N. Yamaguchi, and J. Yokota Prognostic Significance of Allelic Imbalances on Chromosome 9p in Stage I Non-Small Cell Lung Carcinoma Clin. Cancer Res., May 1, 1999; 5(5): 1139 - 1146. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. I. Wistuba, C. Behrens, A. K. Virmani, S. Milchgrub, S. Syed, S. Lam, B. Mackay, J. D. Minna, and A. F. Gazdar Allelic Losses at Chromosome 8p21-23 Are Early and Frequent Events in the Pathogenesis of Lung Cancer Cancer Res., April 1, 1999; 59(8): 1973 - 1979. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Geradts, K. M. Fong, P. V. Zimmerman, R. Maynard, and J. D. Minna Correlation of Abnormal RB, p16ink4a, and p53 Expression with 3p Loss of Heterozygosity, Other Genetic Abnormalities, and Clinical Features in 103 Primary Non-Small Cell Lung Cancers Clin. Cancer Res., April 1, 1999; 5(4): 791 - 800. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Brambilla, S. Gazzeri, D. Moro, S. Lantuejoul, S. Veyrenc, and C. Brambilla Alterations of Rb Pathway (Rb-p16INK4-Cyclin D1) in Preinvasive Bronchial Lesions Clin. Cancer Res., February 1, 1999; 5(2): 243 - 250. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. G. Gorgoulis, P. Zacharatos, A. Kotsinas, T. Liloglou, A. Kyroudi, M. Veslemes, A. Rassidakis, T. D. Halazonetis, J. K. Field, and C. Kittas Alterations of the p16-pRb Pathway and the Chromosome Locus 9p21–22 in Non-Small-Cell Lung Carcinomas : Relationship with p53 and MDM2 Protein Expression Am. J. Pathol., December 1, 1998; 153(6): 1749 - 1765. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M Roland and R M Rudd Genetics and pulmonary medicine bullet 7: Somatic mutations in the development of lung cancer Thorax, November 1, 1998; 53(11): 979 - 983. [Full Text]
|
|
|
|
|
|
W. N. Rom Assessment of Activation, Differentiation, and Carcinogenesis of Lung Cells by Quantitative Competitive RT-PCR Am. J. Respir. Cell Mol. Biol., July 1, 1998; 19(1): 3 - 5. [Full Text]
|
|
|
|
 |
|
 I. I. Wistuba, C. Behrens, S. Milchgrub, A. K. Virmani, J. Jagirdar, B. Thomas, H. L. Ioachim, L. A. Litzky, E. M. Brambilla, J. D. Minna, et al. Comparison of Molecular Changes in Lung Cancers in HIV-Positive and HIV-Indeterminate Subjects JAMA, May 20, 1998; 279(19): 1554 - 1559. [Abstract] [Full Text] [PDF]
|
|